News
Catalyst Pharmaceuticals' Q2 2025 results showcased record revenue, reaffirmed guidance, and growth across key products like FIRDAPSE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback